Profil

BOCK Grégory

Unilab > Laboratoire histologie (CHU)

See author's contact details
Main Referenced Co-authors
Bricmont, Noémie  (1)
Brion, C (1)
Gerday, Sara  (1)
Graff, Sophie  (1)
Guissard, Françoise  (1)
Main Referenced Keywords
asthma (1); biotherapy (1); Cardiology and Cardiovascular Medicine (1); Critical Care and Intensive Care Medicine (1); Pulmonary and Respiratory Medicine (1);
Main Referenced Disciplines
Life sciences: Multidisciplinary, general & others (1)

Publications (total 1)

The most downloaded
149 downloads
Moermans, C., Brion, C., BOCK, G., Graff, S., Gerday, S., Nekoee, H., Poulet, C., Bricmont, N., Henket, M., PAULUS, V., GUISSARD, F., Louis, R., & Schleich, F. (2023). Sputum Type 2 Markers Could Predict Remission in Severe Asthma Treated With Anti-IL-5. CHEST. doi:10.1016/j.chest.2023.01.037 https://hdl.handle.net/2268/303753

The most cited

18 citations (Scopus®)

Moermans, C., Brion, C., BOCK, G., Graff, S., Gerday, S., Nekoee, H., Poulet, C., Bricmont, N., Henket, M., PAULUS, V., GUISSARD, F., Louis, R., & Schleich, F. (2023). Sputum Type 2 Markers Could Predict Remission in Severe Asthma Treated With Anti-IL-5. CHEST. doi:10.1016/j.chest.2023.01.037 https://hdl.handle.net/2268/303753

Moermans, C., Brion, C., BOCK, G., Graff, S., Gerday, S., Nekoee, H., Poulet, C., Bricmont, N., Henket, M., PAULUS, V., GUISSARD, F., Louis, R., & Schleich, F. (2023). Sputum Type 2 Markers Could Predict Remission in Severe Asthma Treated With Anti-IL-5. CHEST. doi:10.1016/j.chest.2023.01.037
Peer Reviewed verified by ORBi

Contact ORBi